(0.24%) 5 143.75 points
(0.24%) 38 532 points
(0.35%) 17 909 points
(-0.80%) $83.18
(1.87%) $1.959
(-0.17%) $2 343.10
(1.30%) $27.61
(0.67%) $928.30
(-0.25%) $0.932
(-0.30%) $10.99
(-0.34%) $0.798
(0.72%) $92.54
0.50% IDR 4 020.00
Live Chart Being Loaded With Signals
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines...
Stats | |
---|---|
Volumen de hoy | 6 500.00 |
Volumen promedio | 55 596.00 |
Capitalización de mercado | 1 800.96B |
EPS | IDR87.11 ( 2023-09-30 ) |
Próxima fecha de ganancias | ( IDR0 ) 2024-05-29 |
Last Dividend | IDR0 ( N/A ) |
Next Dividend | IDR0 ( N/A ) |
P/E | 10.10 |
ATR14 | IDR11.56 (0.29%) |
PT Merck Tbk Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PT Merck Tbk Finanzas
Annual | 2023 |
Ingresos: | IDR961.43B |
Beneficio Bruto: | IDR391.73B (40.74 %) |
EPS: | IDR397.86 |
FY | 2023 |
Ingresos: | IDR961.43B |
Beneficio Bruto: | IDR391.73B (40.74 %) |
EPS: | IDR397.86 |
FY | 2022 |
Ingresos: | IDR1 124.60B |
Beneficio Bruto: | IDR427.59B (38.02 %) |
EPS: | IDR401.42 |
FY | 2021 |
Ingresos: | IDR1 064.39B |
Beneficio Bruto: | IDR398.68B (37.46 %) |
EPS: | IDR293.89 |
Financial Reports:
No articles found.
PT Merck Tbk
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico